You Searched For "moderna stock" and got 20 results
Sort By:
2 mins read
Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine
The move is welcomed by investors because if successful, it would help Moderna diversify its revenu…
Matthew Fox
1 min read
Moderna climbs as 4th-quarter sales blow past expectations and 2021 forecasts surge
The company during its earnings call also announced the September departure of Tal Zaks, its chief …
Max Adams
2 mins read
Moderna's billionaire CEO draws criticism for earning nearly $400 million in stock options last year, and then getting a raise on top of it
The exec donated $176 million after-tax to charity last year and pledged to continue, but analysts …
Jordan Hart
2 mins read
Moderna, BioNTech, and Novavax plunge after President Biden says the COVID-19 pandemic 'is over'
"The pandemic is over. We still have a problem with COVID. We're still doing a low of work on it. B…
Matthew Fox
1 min read
Moderna and BioNTech stocks are surging amid reports of FDA vaccine-approval progress
Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headl…
Ethan Wu
2 mins read
Moderna climbs 7% as Morgan Stanley says it could fill a vaccine-demand void left by Pfizer
Morgan Stanley said on Tuesday that Moderna may provide the vast majority of COVID-19 vaccine doses…
Emily Graffeo
2 mins read
Moderna slides 7% even as FDA confirms vaccine's effectiveness and safety
The decline comes with Moderna's stock having surged 693% year-to-date through Monday's close.
Ben Winck
1 min read
Moderna sinks 6% as investors continue to secure profits from massive vaccine rally
Moderna is awaiting FDA authorization after a panel of experts recommended the vaccine be approved …
Emily Graffeo
1 min read
Moderna climbs 12% after saying its coronavirus vaccine likely protects against new strains found in the UK and South Africa
Moderna stock jumped after the biotech company said its COVID-19 vaccine can likely protect against…
Emily Graffeo
1 min read
Merck sells its investment stake in Moderna after recording a 'substantial' gain
Merck initially invested $50 million in Moderna before it was public in 2015, and subsequently inve…
Matthew Fox
2 mins read
Pfizer and AstraZeneca slide as Moderna's rival COVID-19 vaccine shows strong efficacy
Investors may be picking sides in terms of a COVID-19 vaccine developer, as there are big differenc…
Matthew Fox
2 mins read
Moderna soars 10% after results show its COVID-19 vaccine is almost 95% effective
The US drugmaker said it was informed by the Data Safety Monitoring Board that its vaccine had met …
Shalini Nagarajan
2 mins read
Moderna soars 16% after announcing plans to file for emergency use authorization as results indicate its COVID-19 vaccine is 94% effective
Moderna said the vaccine was more than 94% effective at preventing people in its late-stage trial f…
Shalini Nagarajan
2 mins read
Moderna stock plummeted on Biden's support of waiving vaccine patent protections, but that backing won't have a material impact on the company, Morgan Stanley says
"Any new manufacturing operation could take 6-9 months to scale," said Morgan Stanley about compani…
Carla Mozée
1 min read
Moderna slumps 11% as the vaccine-maker's Q1 revenue misses estimates
The pharma company's full-year sales forecast for its vaccine was raised to $19.2 billion, up from …
Shalini Nagarajan
1 min read
Moderna surges 9% after California authorizes vaccine batch following allergy scare
State epidemiologist Dr. Erica Pan said the state found "no scientific basis to continue the pause"…
Will Daniel
1 min read
The so-called reopening trade surges on Moderna vaccine trial success
The reopening trade consists of stocks that would benefit from the US economy returning to normal f…
Carmen Reinicke
2 mins read
Moderna surges 10% after Trump says US government reached deal for 100 million doses of its coronavirus vaccine
Moderna separately said the deal is worth $1.53 billion, and the government can purchase up to 400 …
Carmen Reinicke
2 mins read
Moderna skyrockets 11% after receiving additional $472 million of funding, starting phase-3 trial of COVID-19 vaccine
Moderna's total award from the Biomedical Advanced Research and Development Authority is roughly $9…
Carmen Reinicke
3 mins read
A California Democrat running for Congress failed to disclose investments in Moderna and Pfizer stocks
The candidate, Jay Chen, did not disclose the investments until Insider contacted his campaign with…